CBX Capital Review
90
Review
Fast Facts
Contact Info and Support
Traffic information
| Category | Metrics | Meaning |
|---|---|---|
| Ratings | Global Rank | - |
| Country Code | - | |
| Country Rank | - | |
| Category Rank | - | |
| Engagement metrics | Visits | 0 |
| Bounce Rate | 0 | |
| Pageviews per Visit | 0 | |
| Avg. Visit Duration | 0 | |
| Estimated monthly visits | July 2025 | 0 |
| August 2025 | 0 | |
| September 2025 | 0 | |
| Traffic sources | Social | - |
| Paid Referrals | - | |
| - | ||
| Referrals | - | |
| Search | - | |
| Direct | - |
About CBX Capital
CBX Capital is not authorised by the UK Financial Conduct Authority (FCA) and has received a warning from the FCA indicating it is providing financial services or products in the UK without authorisation. The warning was issued on 13 October 2023 concerning domain cbxcapital.com (). The Austrian Financial Market Authority (FMA) similarly issued an investor warning on 29 September 2023 stating that CBX Capital, with its registered address in London, is not permitted to carry out banking or trading transactions in Austria (). CBX Capital lacks any recognised regulation, guarantees of segregated client funds, negative balance protection, or transparency regarding account types, trading conditions, minimum deposit, spreads, or leverage ().
Who it’s for
- This entity is not suitable for any investor seeking regulated trading services.
- Not appropriate for traders expecting fund safety, transparent conditions, or legal protection.
Pros and cons
Pros
- None; no factual basis for any advantages.
Cons
- Unregulated by any recognised financial authority.
- Received FCA warning (13 October 2023) for unauthorised operations via
cbxcapital.com. - FMA (Austria) explicitly warns against transactions with CBX Capital (29 September 2023).
- No transparency on key trading conditions (minimum deposit, spreads, leverage, fees, account types).
- No client fund protections such as segregation or negative balance protection.
- Multiple external sources report red flags and high risk ().
